• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组织化学在甲状腺病理学中的应用。

Application of immunohistochemistry in thyroid pathology.

作者信息

Liu Haiyan, Lin Fan

机构信息

From the Department of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania.

出版信息

Arch Pathol Lab Med. 2015 Jan;139(1):67-82. doi: 10.5858/arpa.2014-0056-RA.

DOI:10.5858/arpa.2014-0056-RA
PMID:25549145
Abstract

CONTEXT

Accurate classification of follicular-patterned thyroid lesions is not always an easy task on routine surgical hematoxylin-eosin-stained or cytologic fine-needle aspiration specimens. The diagnostic challenges are partially due to differential diagnostic criteria that are often subtle and subjective. In the past decades, tremendous advances have been made in molecular gene profiling of tumors and diagnostic immunohistochemistry, aiding in diagnostic accuracy and proper patient management.

OBJECTIVE

To evaluate the diagnostic utility of the most commonly studied immunomarkers in the field of thyroid pathology by review of the literature, using the database of indexed articles in PubMed (US National Library of Medicine) from 1976-2013.

DATA SOURCES

Literature review, authors' research data, and personal practice experience.

CONCLUSIONS

The appropriate use of immunohistochemistry by applying a panel of immunomarkers and using a standardized technical and interpretational method may complement the morphologic assessment and aid in the accurate classification of difficult thyroid lesions.

摘要

背景

在常规手术苏木精 - 伊红染色或细针穿刺细胞学标本上,准确分类滤泡型甲状腺病变并非总是易事。诊断难题部分归因于鉴别诊断标准往往细微且主观。在过去几十年中,肿瘤分子基因谱分析和诊断性免疫组化取得了巨大进展,有助于提高诊断准确性和恰当的患者管理。

目的

通过回顾文献,利用美国国立医学图书馆PubMed数据库中1976 - 2013年索引文章的数据库,评估甲状腺病理学领域最常研究的免疫标志物的诊断效用。

数据来源

文献综述、作者的研究数据和个人实践经验。

结论

通过应用一组免疫标志物并采用标准化的技术和解释方法来适当使用免疫组化,可能补充形态学评估并有助于准确分类疑难甲状腺病变。

相似文献

1
Application of immunohistochemistry in thyroid pathology.免疫组织化学在甲状腺病理学中的应用。
Arch Pathol Lab Med. 2015 Jan;139(1):67-82. doi: 10.5858/arpa.2014-0056-RA.
2
Application of immunohistochemistry in breast pathology: a review and update.免疫组织化学在乳腺病理学中的应用:综述与更新
Arch Pathol Lab Med. 2014 Dec;138(12):1629-42. doi: 10.5858/arpa.2014-0094-RA.
3
Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.使用一组免疫组织化学标志物对细针穿刺细胞学标本中的甲状腺“滤泡性肿瘤”进行特征分析:临床应用建议
Endocr Relat Cancer. 2005 Jun;12(2):305-17. doi: 10.1677/erc.1.00944.
4
Application of immunohistochemistry to thyroid neoplasms.免疫组织化学在甲状腺肿瘤中的应用。
Arch Pathol Lab Med. 2008 Mar;132(3):359-72. doi: 10.5858/2008-132-359-AOITTN.
5
Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.HBME-1和半乳糖凝集素-3的同步免疫组化表达可将甲状腺乳头状癌与甲状腺功能亢进性病变区分开来。
Histopathology. 2006 Jun;48(7):795-800. doi: 10.1111/j.1365-2559.2006.02428.x.
6
Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.CD56免疫组化在甲状腺乳头状癌中的诊断效用
Pathol Res Pract. 2009;205(5):303-9. doi: 10.1016/j.prp.2008.11.011. Epub 2009 Jan 18.
7
[Cytodiagnosis by fine-needle aspiration (FNAB) in thyroid dysplasias and neoplasms observed in 1983-1987].[1983年至1987年观察到的甲状腺发育异常和肿瘤的细针穿刺抽吸(FNAB)细胞诊断]
Minerva Med. 1989 May;80(5):435-8.
8
Biomarker panel diagnosis of thyroid cancer: a critical review.甲状腺癌的生物标志物组合诊断:一项批判性综述。
Expert Rev Anticancer Ther. 2008 Sep;8(9):1399-413. doi: 10.1586/14737140.8.9.1399.
9
Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.甲状腺乳头状癌的细针穿刺活检:细胞角蛋白19免疫染色的诊断效用
Cancer. 2000 Oct 25;90(5):307-11.
10
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.半乳糖凝集素-3不能可靠地区分甲状腺良性肿瘤和恶性肿瘤。
Histopathology. 2006 Jan;48(2):212-3. doi: 10.1111/j.1365-2559.2005.02214.x.

引用本文的文献

1
Differential diagnosis of Hashimoto's thyroiditis: The importance of pathological anatomy.桥本甲状腺炎的鉴别诊断:病理解剖学的重要性。
J Biol Methods. 2025 Aug 7;12(3):e99010064. doi: 10.14440/jbm.2024.0139. eCollection 2025.
2
Immunohistochemical Expression of HBME-1 in a Spectrum of Thyroid Neoplasms.HBME-1在一系列甲状腺肿瘤中的免疫组化表达
Indian J Endocrinol Metab. 2024 Nov-Dec;28(6):629-632. doi: 10.4103/ijem.ijem_451_23. Epub 2024 Oct 17.
3
Insights into the Multidisciplinary Approach for Metastatic Acinic Cell Lung Carcinoma: The Pathologist's Role in Romania Today.
转移性腺泡细胞肺癌多学科治疗方法的见解:当今罗马尼亚病理学家的作用。
Curr Oncol. 2025 Jan 13;32(1):37. doi: 10.3390/curroncol32010037.
4
The Landmark Series: Testing in Thyroid Nodule Fine Needle Aspiration Cytology.里程碑系列:甲状腺结节细针穿刺细胞学检查
Ann Surg Oncol. 2025 Apr;32(4):2323-2328. doi: 10.1245/s10434-024-16843-z. Epub 2025 Jan 16.
5
Immunohistochemical Study Protocol in Thyroid Pathology.甲状腺病理学中的免疫组织化学研究方案。
Methods Mol Biol. 2025;2876:221-239. doi: 10.1007/978-1-0716-4252-8_15.
6
Malignant Transformation in a Mature Cystic Teratoma of the Ovary: A 5-year Descriptive Study.卵巢成熟性囊性畸胎瘤的恶性转化:一项为期5年的描述性研究。
Acta Med Philipp. 2024 Aug 30;58(15):55-60. doi: 10.47895/amp.vi0.8023. eCollection 2024.
7
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.炎症与癌症期间的诊断挑战:当前生物标志物以及消化系统中反应性、发育异常和癌性病变雷区导航的未来展望
Int J Mol Sci. 2024 Jan 19;25(2):1251. doi: 10.3390/ijms25021251.
8
A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma.NTRK 重排型甲状腺乳头状癌的误诊病例
Oncologist. 2024 Jan 5;29(1):84-88. doi: 10.1093/oncolo/oyad310.
9
Performance of ACR TI-RADS and the Bethesda System in Predicting Risk of Malignancy in Thyroid Nodules at a Large Children's Hospital and a Comprehensive Review of the Pediatric Literature.ACR TI-RADS和贝塞斯达系统在一家大型儿童医院预测甲状腺结节恶性风险中的表现及儿科文献综述
Cancers (Basel). 2023 Aug 4;15(15):3975. doi: 10.3390/cancers15153975.
10
Cytokeratin 19 (CK19) expression by thyroid neoplasms in a Nigerian tertiary health centre.尼日利亚一家三级保健中心的甲状腺肿瘤中细胞角蛋白 19(CK19)的表达。
Pan Afr Med J. 2023 Apr 14;44:176. doi: 10.11604/pamj.2023.44.176.37751. eCollection 2023.